Company Filing History:
2 out of 1,251 
1 out of 1 
1 out of 3 Years Active: 2017-2018
Title: Nojoon Song: Innovator in Obesity Treatment
Introduction
Nojoon Song is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of obesity treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on methods and compositions that aim to manage and prevent obesity.
Latest Patents
Nojoon Song's latest patents include a method for treating, managing, inhibiting, or preventing obesity. This invention features a composition designed to induce differentiation into beige adipocytes from white adipocytes. The active ingredients include butein, a butein derivative, or a pharmaceutically available salt thereof. The method has been confirmed to increase expressions of UCP-1 and PRDM4, indicating its potential for preventing or treating obesity effectively.
Another notable patent by Song is a composition for inducing differentiation into beige and brown adipocytes. Similar to his previous work, this composition also includes butein or its derivatives as active ingredients. The expected outcomes of this invention are aimed at targeted treatment for obesity, showcasing the innovative approaches that Song has developed in this critical area of health.
Career Highlights
Throughout his career, Nojoon Song has been associated with reputable institutions such as Sungkyunkwan University and the Gyeonggi Institute of Science & Technology Promotion. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Some of his notable coworkers include Kye Won Park and Suk Chan Lee. Their collaborative efforts have likely enhanced the research and development of innovative solutions in the field of obesity treatment.
Conclusion
Nojoon Song's contributions to obesity treatment through his patented inventions highlight his role as a leading innovator in this field. His work not only addresses a significant health issue but also paves the way for future advancements in targeted therapies.